AU2001237379A1 - Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction - Google Patents
Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunctionInfo
- Publication number
- AU2001237379A1 AU2001237379A1 AU2001237379A AU2001237379A AU2001237379A1 AU 2001237379 A1 AU2001237379 A1 AU 2001237379A1 AU 2001237379 A AU2001237379 A AU 2001237379A AU 2001237379 A AU2001237379 A AU 2001237379A AU 2001237379 A1 AU2001237379 A1 AU 2001237379A1
- Authority
- AU
- Australia
- Prior art keywords
- benzothieno
- pde
- pyrimidines
- treatment
- inhibitory effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000010228 Erectile Dysfunction Diseases 0.000 title 1
- 201000001881 impotence Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10010612A DE10010612A1 (en) | 2000-03-03 | 2000-03-03 | Treatment of erectile dysfunction without inducing circulatory side-effects, using penis-specific phosphodiesterase V inhibitors, preferably benzo (4,5) thieno (2,3-d) pyrimidine derivatives |
DE10010612.9 | 2000-03-03 | ||
PCT/EP2001/001557 WO2001064192A2 (en) | 2000-03-03 | 2001-02-13 | Use of benzothieno-2,3-d-pyrimidines with pde v inhibitory effect for the treatment of erectile dysfunction |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001237379A1 true AU2001237379A1 (en) | 2001-11-22 |
AU2001237379B2 AU2001237379B2 (en) | 2005-05-05 |
Family
ID=7633516
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001237379A Ceased AU2001237379B2 (en) | 2000-03-03 | 2001-02-13 | Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction |
AU3737901A Pending AU3737901A (en) | 2000-03-03 | 2001-02-13 | Use of pde v inhibitors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU3737901A Pending AU3737901A (en) | 2000-03-03 | 2001-02-13 | Use of pde v inhibitors |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030022906A1 (en) |
EP (1) | EP1259229B1 (en) |
JP (1) | JP2004504269A (en) |
AT (1) | ATE297719T1 (en) |
AU (2) | AU2001237379B2 (en) |
CA (1) | CA2401585A1 (en) |
CO (1) | CO5210873A1 (en) |
DE (2) | DE10010612A1 (en) |
ES (1) | ES2241798T3 (en) |
MX (1) | MXPA02008571A (en) |
PE (1) | PE20011165A1 (en) |
PT (1) | PT1259229E (en) |
WO (1) | WO2001064192A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10031585A1 (en) * | 2000-06-29 | 2002-01-10 | Merck Patent Gmbh | 2-aminoalkyl-thieno [2,3-d] pyrimidine |
JPWO2003035653A1 (en) * | 2001-10-26 | 2005-02-10 | 日本曹達株式会社 | Pyridothienopyrimidine compounds and salts thereof |
US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
CA2694009A1 (en) * | 2007-07-26 | 2009-01-29 | F. Hoffmann-La Roche Ag | Dual modulators of 5-ht2a and d3 receptors |
CN104945412B (en) * | 2015-05-26 | 2018-01-23 | 温州医科大学 | Tetrahydro benzo thieno [2,3 d] aminopyridine derivative for FGFR1 and preparation method and application |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL132993A0 (en) * | 1997-05-29 | 2001-03-19 | Mochida Pharm Co Ltd | Therapeutic agent for erection failure |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
DE19819023A1 (en) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidines |
US6265420B1 (en) * | 1998-06-23 | 2001-07-24 | Medinox, Inc. | Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
EP1112069A2 (en) * | 1998-08-25 | 2001-07-04 | Alpharma-Isis GmbH & Co. KG | Medicament utilization and combination |
MXPA00003997A (en) * | 1999-04-30 | 2002-03-08 | Lilly Icos Llc | Articles of manufacture. |
DE19928146A1 (en) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence |
US6476037B1 (en) * | 2000-03-23 | 2002-11-05 | The Regents Of The University Of California | L-arginine and phosphodiesterase (PDE) inhibitor synergism |
-
2000
- 2000-03-03 DE DE10010612A patent/DE10010612A1/en not_active Withdrawn
-
2001
- 2001-02-13 AT AT01909743T patent/ATE297719T1/en not_active IP Right Cessation
- 2001-02-13 CA CA002401585A patent/CA2401585A1/en not_active Abandoned
- 2001-02-13 ES ES01909743T patent/ES2241798T3/en not_active Expired - Lifetime
- 2001-02-13 DE DE50106519T patent/DE50106519D1/en not_active Expired - Fee Related
- 2001-02-13 US US10/220,416 patent/US20030022906A1/en not_active Abandoned
- 2001-02-13 AU AU2001237379A patent/AU2001237379B2/en not_active Ceased
- 2001-02-13 WO PCT/EP2001/001557 patent/WO2001064192A2/en active IP Right Grant
- 2001-02-13 PT PT01909743T patent/PT1259229E/en unknown
- 2001-02-13 EP EP01909743A patent/EP1259229B1/en not_active Expired - Lifetime
- 2001-02-13 MX MXPA02008571A patent/MXPA02008571A/en unknown
- 2001-02-13 JP JP2001563089A patent/JP2004504269A/en active Pending
- 2001-02-13 AU AU3737901A patent/AU3737901A/en active Pending
- 2001-03-01 PE PE2001000209A patent/PE20011165A1/en not_active Application Discontinuation
- 2001-03-02 CO CO01016924A patent/CO5210873A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4583899A (en) | Nasal administration of sildenafil for the treatment of erectile dysfunction | |
IL138907A0 (en) | Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction | |
MXPA03002814A (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases. | |
IL157320A0 (en) | Rapid-onset medicament for the treatment of sexual dysfunction | |
IL222455A0 (en) | Methods for the preparation, isolation and purification of epothilone b | |
NO20024364D0 (en) | Use of pyrido [3,2-E] pyrazinones as inhibitors of phosphodiesterase 5 for the treatment of erectile dysfunction | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
AU2001250821A1 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
AU2001274649A1 (en) | Topical preparation of alprostadil for the treatment of erectile dysfunction | |
AU2002238106A1 (en) | Melanocortin metallopeptides for treatment of sexual dysfunction | |
AU2003219981A1 (en) | Benzimidazole-derivatives for the treatment of sexual dysfunction | |
AU2001260834A1 (en) | The treatment of herpes | |
HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
IL162154A0 (en) | Prostagandin composition for the treatment of erectile dysfunction | |
AU2003291886A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
AU2001237379A1 (en) | Use of benzothieno-2,3-D-pyrimidines with PDE V inhibitory effect for the treatment of erectile dysfunction | |
AU2002246924A1 (en) | Treatment of erectile dysfunction with rho-kinase inhibitors | |
AU7652400A (en) | Novel combination for the treatment of sexual dysfunction | |
AU2001278680A1 (en) | Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient | |
AU2001284125A1 (en) | Medicine for fighting against sexual dysfunction | |
ZA200203069B (en) | Peptides for treatment of erectile dysfunction. | |
AU2000275972A1 (en) | Pde iii inhibitors for treating sexual dysfunction | |
EP1395593A4 (en) | Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction | |
AU2001292500A1 (en) | 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain | |
AU2001250530A1 (en) | Treatment of conditions of the central nervous system using mycobacteria |